Company intelligence / Profile preview

Light-Hope Diagnostics

Salt Lake City, Utah, United Stateslighthopelife.org ↗

Ownership: Private
Development stage: Preclinical

Overview

Light-Hope Diagnostics is developing a non-invasive, affordable liquid biopsy test using proprietary multiplex PCR to detect cancer-specific non-coding RNAs for early diagnosis of multiple cancers. Their first product is undergoing analytical and clinical validation with plans to target low/middle-income countries through cost-effective manufacturing and distribution strategies.

Therapeutic areas: Oncology
Modalities: PCR-based diagnostic testLiquid biopsy
Industry: Molecular Diagnostics

Partnerships

Collaborations with Indian cancer hospitals for clinical trials; seeking further partners/investors in USA and India.

Beyond the preview

Go deeper on Light-Hope Diagnostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Light-Hope Diagnostics.

Explore the full profile